Recent Analyst Forecasts and Stock Ratings
Monopar Therapeutics Inc. FAQ's
Monopar Therapeutics Inc. has been rated by research analysts at Raymond James, Barclays, Oppenheimer, H.C. Wainwright, Chardan Capital, Piper Sandler in the past 90 days.
Monopar Therapeutics Inc. has been rated by research analysts at Raymond James, Barclays, Oppenheimer, H.C. Wainwright, Chardan Capital, Piper Sandler in the past 90 days.